Literature DB >> 21269331

An autopsied case of V180I Creutzfeldt-Jakob disease presenting with panencephalopathic-type pathology and a characteristic prion protein type.

Yasushi Iwasaki1, Keiko Mori, Masumi Ito, Masamitsu Nagaoka, Toshiaki Ieda, Tetsuyuki Kitamoto, Mari Yoshida, Yoshio Hashizume.   

Abstract

A 73-year-old Japanese woman showed slowly progressive aphasia, apraxia and dementia. She had no family history of prion disease or dementia. One year later she showed parkinsonism and corticobasal degeneration was initially suspected. On MRI, the left temporal neocortex seemed swollen on T2-weighted images in the initial stage, and a later high-signal intensity region was observed in the cerebral cortex in diffusion-weighted images. The patient developed myoclonus and an akinetic mutism state 15 months and 22 months after onset, respectively. Consecutive electroencephalography revealed no periodic sharp-wave complexes. Prion protein (PrP) gene analysis revealed a valine to isoleucine point mutation at codon 180, and methionine homozygosity at codon 129. This patient's clinical symptoms and disease course were atypical for Creutzfeldt-Jakob disease (CJD), and a stable state with nasal tube-feeding lasted several years. She died of respiratory failure at the age of 81, 102 months after the onset. Autopsy revealed widespread spongiform degeneration with weak synaptic-type PrP deposition, confirming the diagnosis of genetic CJD. Neurons in the cerebral cortex were relatively preserved in number and hypertrophic astrocytosis was generally moderate for such long-term disease, but cerebral white matter showed diffuse severe myelin pallor with tissue rarefaction suggestive of panencephalopatic-type pathology. The cerebellar cortex was relatively well preserved with observation of mild spongiform change in the molecular layer, moderate neuron loss in the Purkinje neuron layer, and scattered small plaque-like PrP deposition. Western blot analysis of protease-resistant PrP showed a characteristic pattern without a diglycoform band. V180I CJD is an interesting form of genetic CJD with regards to the clinicopathologic, molecular and genetic findings.
© 2011 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269331     DOI: 10.1111/j.1440-1789.2010.01192.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  13 in total

1.  Gastrostomy in patients with prion disease.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai; Ken-Ichiro Hoshino; Yuko Kawabata; Maya Mimuro; Mari Yoshida
Journal:  Prion       Date:  2017-05-16       Impact factor: 3.931

2.  Do prion protein gene polymorphisms induce apoptosis in non-mammals?

Authors:  Tuğçe Birkan; Mesut Şahin; Zubeyde Öztel; Erdal Balcan
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

3.  Pathological progression of genetic Creutzfeldt-Jakob disease with a PrP V180I mutation.

Authors:  Akio Akagi; Yasushi Iwasaki; Maya Mimuro; Tetsuyuki Kitamoto; Masahito Yamada; Mari Yoshida
Journal:  Prion       Date:  2018-01-31       Impact factor: 3.931

4.  Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia.

Authors:  David Y Johnson; Diana L Dunkelberger; Maya Henry; Aissatou Haman; Michael D Greicius; Katherine Wong; Stephen J DeArmond; Bruce L Miller; Maria Luisa Gorno-Tempini; Michael D Geschwind
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

5.  Spreading brain lesions in a familial Creutzfeldt-Jakob disease with V180I mutation over 4 years.

Authors:  Kentaro Deguchi; Motonori Takamiya; Shoko Deguchi; Nobutoshi Morimoto; Tomoko Kurata; Yoshio Ikeda; Koji Abe
Journal:  BMC Neurol       Date:  2012-11-24       Impact factor: 2.474

6.  Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.

Authors:  Maya Higuma; Nobuo Sanjo; Katsuya Satoh; Yusei Shiga; Kenji Sakai; Ichiro Nozaki; Tsuyoshi Hamaguchi; Yosikazu Nakamura; Tetsuyuki Kitamoto; Susumu Shirabe; Shigeo Murayama; Masahito Yamada; Jun Tateishi; Hidehiro Mizusawa
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

7.  Clinical features of genetic Creutzfeldt-Jakob disease with V180I mutation in the prion protein gene.

Authors:  Temu Qina; Nobuo Sanjo; Masaki Hizume; Maya Higuma; Makoto Tomita; Ryuichiro Atarashi; Katsuya Satoh; Ichiro Nozaki; Tsuyoshi Hamaguchi; Yosikazu Nakamura; Atsushi Kobayashi; Tetsuyuki Kitamoto; Shigeo Murayama; Hiroyuki Murai; Masahito Yamada; Hidehiro Mizusawa
Journal:  BMJ Open       Date:  2014-05-16       Impact factor: 2.692

Review 8.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

9.  A case of V180I genetic Creutzfeldt-Jakob disease presenting with conspicuous facial mimicry.

Authors:  Yasushi Iwasaki; Keiko Mori; Masumi Ito; Yoshinari Kawai
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

10.  Clinicopathological findings of a long-term survivor of V180I genetic Creutzfeldt-Jakob disease.

Authors:  Yuichi Hayashi; Yasushi Iwasaki; Masahiro Waza; Shinei Kato; Akio Akagi; Akio Kimura; Takashi Inuzuka; Katsuya Satoh; Tetsuyuki Kitamoto; Mari Yoshida; Takayoshi Shimohata
Journal:  Prion       Date:  2020-12       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.